Mike Lunn

59PUBLICATIONS
147CO-AUTHORS
Biological physicsProteins and peptidesNeurology and neuromuscular diseasesRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Jul 13, 2026
Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

|Jun 16, 2026
Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

|May 20, 2026
Acquired vitamin B6 deficiency in POEMS: a marker of disease activity and cause of neuropathy?

|Mar 23, 2026
Front-line systemic treatment outcomes in POEMS syndrome.

Oliver Tomkins, Jahanzaib Khwaja, Shiwen Koay

|Feb 27, 2026
Intravenous methylprednisolone as add-on induction therapy for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.

Sander R M Bus, Iris N van Doorn, Laura Zambreanu

|Feb 19, 2026
What is refractory CIDP?

Aisling Carr, Michael P Lunn

Pageof 10

Frequent Collaborators

14 joint publications

Stephen Keddie

6 joint publications

Thomas Harbo

6 joint publications

Luis Querol

5 joint publications

Robert D M Hadden